Necrotizing fasciitis: Difference between revisions
No edit summary |
|||
(26 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*A | *A rapidly progressive infection primarily involving the fascia and subcutaneous tissue | ||
*Formerly a rare diagnosis, frequency has risen due to an increase in immunocompromised patients with significant risk factors<ref>Hakkarainen TW et al. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014 Aug. 51 (8):344-72.</ref> | |||
*Gas-formation is NOT a requirement for diagnosis, and radiographical lack of the classically taught gas formation should NEVER rule out necrotizing infection<ref>Misiakos EP et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014. 1:36.</ref> | |||
*Most severe form of soft tissue infection and potentially limb and life threatening | *Most severe form of soft tissue infection and potentially limb and life threatening | ||
*Early recognition and aggressive debridement | *Early recognition and aggressive debridement are major prognostic determinants and delay increases mortality<ref>Wong CH, Khin LW, Heng KS, Tan KC, Low CO (2004). "The LRINEC Laboratory Rother soft tissue infections". Critical Care Medicine 32 (7): 1535–1541. doi:10.1097/01.CCM.0000129486.35458.7D. PMID 15241098</ref> | ||
===Categories=== | |||
*Type I, polymicrobial | |||
*Type II, [[group A streptococcal]] | |||
*Type III, gas gangrene or [[clostridial]] myonecrosis | |||
===Risk Factors=== | ===Risk Factors=== | ||
*[[DM]] | *[[DM]] | ||
Line 12: | Line 20: | ||
==Clinical Features== | ==Clinical Features== | ||
[[File:NectrotizingFasciitis.jpeg| | [[File:NectrotizingFasciitis.jpeg|thumb|Nectrotizing fasciitis]] | ||
*Skin exam | *Skin exam | ||
**Erythema (without sharp margins) | **Erythema (without sharp margins) | ||
**Exquisitely tender (pain out of proportion to exam) | **Exquisitely tender (pain out of proportion to exam) | ||
***Caveat - some patients present with "la belle indifference" | |||
***May be a result of ischemic, insensate tissue<ref>TheHealthScience. Emergent Management of Necrotizing Soft Tissue Skin Infections. Nov 22, 2013. https://thehealthscience.com/topics/emergent-management-necrotizing-soft-tissue-skin-infections.</ref> | |||
**Skip lesions | **Skip lesions | ||
**Hemorrhagic bullae (violaceous bullae) | **Hemorrhagic bullae (violaceous bullae) | ||
***May be preceded by skin anesthesia (destruction of superficial nerves) | ***May be preceded by skin anesthesia (destruction of superficial nerves) | ||
**Crepitus (in type I infections) | **Crepitus (in type I infections) | ||
**Lymphangitis and lymphadenopathy are absent in necrotizing fasciitis alone<ref>Seal DV. Necrotizing fasciitis. Curr Opin Infect Dis. 2001;14(2):127–32.</ref><ref>Golger A, Ching S, Goldsmith CH, Pennie RA, Bain JR. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg. 2007;119(6):1803–7.</ref> | |||
***Lymphangitis is seen in [[cellulitis]] | |||
***Fascia has no lymph drainage | |||
*Swelling/edema may produce compartment syndrome | *Swelling/edema may produce compartment syndrome | ||
*Constitutional | *Constitutional or toxic shock-like syndrome<ref>Puvanendran R et al. Necrotizing fasciitis. Can Fam Physician. 2009 Oct; 55(10): 981–987.</ref> | ||
**Fever | **Fever | ||
**Tachycardia | **Tachycardia | ||
**Systemic toxicity | **Systemic toxicity, [[sepsis]] | ||
**[[Conjunctivitis]] | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{ | {{SSTI DDX}} | ||
{{Necrotizing Rashes DDX}} | |||
== | ==Evaluation== | ||
[[File:CTNecrotizingFasciitis.png|thumb|CT of necrotizing fasciitis]] | |||
===Work-Up=== | ===Work-Up=== | ||
*CBC | *CBC | ||
Line 38: | Line 54: | ||
===Evaluation=== | ===Evaluation=== | ||
*Surgical exploration is the ONLY way to definitively establish the diagnosis of necrotizing infection | *Surgical exploration is the ONLY way to definitively establish the diagnosis of necrotizing infection | ||
*Imaging | *Imaging | ||
**Should not delay surgical exploration | **Should not delay surgical exploration | ||
**CT is study of choice | **CT is study of choice - soft tissue gas, edema and fluid collections, fascial thickening with fat stranding | ||
**US may show thickened fascial planes, fluid between fascial planes, irregularity of the fascia, subcutaneous emphysema. The study may be limited by soft tissue gas | |||
**MRI - T2 subcutaneous, intramuscular, and fascial edema | |||
*Absence of gas on imaging '''does not''' exclude diagnosis, as gas may be occult and/or certain organisms do not classically produce gas (i.e. Group A Strep) | |||
{{LRINEC SCORE}} | |||
===HUCLA NF vs Non-NF Criteria | ===HUCLA NF vs Non-NF Criteria:<ref>Wall DB et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000 Sep;191(3):227-31.</ref>=== | ||
*Retrospective study discovered: | |||
**'''WBC count''' '''>15.4'''(x10<sup>3</sup>/mm<sup>3</sup>) OR '''Na''' '''<135'''(mmol/L) | **'''WBC count''' '''>15.4'''(x10<sup>3</sup>/mm<sup>3</sup>) OR '''Na''' '''<135'''(mmol/L) | ||
**Associated with NF and combo of both increased likelihood of NF | **Associated with NF and combo of both increased likelihood of NF | ||
Line 52: | Line 71: | ||
**Helps distinguish NF from non-NF infection, when classic 'hard' signs of NF are absent however clinical judgment should still be used in patient with high suspicion of the disease | **Helps distinguish NF from non-NF infection, when classic 'hard' signs of NF are absent however clinical judgment should still be used in patient with high suspicion of the disease | ||
== | ==Management== | ||
*Surgical exploration and debridement is both the definitive diagnostic modality and the definitive treatment | *Surgical exploration and debridement is both the definitive diagnostic modality and the definitive treatment | ||
**Indicated in setting of severe pain, toxicity, fever, elevated CK ( | **Indicated in setting of severe pain, toxicity, fever, elevated CK (with or without radiographic evidence) | ||
*[[Antibiotics]] | *[[Antibiotics]] | ||
**Must cover | **Must cover [[gram positives]], [[gram negatives]], and [[anaerobes]] (especially [[GAS]] and [[clostridium]]) | ||
**[[Piperacillin-Tazobactam]] 3.375-4.5g q6hr AND [[clindamycin]] 600-900mg q8hr AND [[vancomycin]] 1gm IV q12hr | **[[Piperacillin-Tazobactam]] 3.375-4.5g q6hr AND [[clindamycin]] 600-900mg q8hr AND [[vancomycin]] 1gm IV q12hr (consider weight base dosing of 20 mg/kg) | ||
* | *In diabetics, maintain strict glycemic control (with IVFs and IV insulin if necessary) | ||
==Disposition== | ==Disposition== | ||
*Admit | *Admit to ICU | ||
==See Also== | ==See Also== | ||
*[[Necrotizing | *[[Necrotizing soft tissue infections]] | ||
*[[LRINEC_score|Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score]] | |||
*[[EBQ:LRINEC Score]] | *[[EBQ:LRINEC Score]] | ||
==Video== | |||
{{#widget:YouTube|id=-VC1f88MZWU}} | |||
==References== | ==References== |
Revision as of 16:49, 10 September 2020
Background
- A rapidly progressive infection primarily involving the fascia and subcutaneous tissue
- Formerly a rare diagnosis, frequency has risen due to an increase in immunocompromised patients with significant risk factors[1]
- Gas-formation is NOT a requirement for diagnosis, and radiographical lack of the classically taught gas formation should NEVER rule out necrotizing infection[2]
- Most severe form of soft tissue infection and potentially limb and life threatening
- Early recognition and aggressive debridement are major prognostic determinants and delay increases mortality[3]
Categories
- Type I, polymicrobial
- Type II, group A streptococcal
- Type III, gas gangrene or clostridial myonecrosis
Risk Factors
- DM
- Drug use
- Obesity
- Immunosuppression
- Recent surgery
- Traumatic wounds
Clinical Features
- Skin exam
- Erythema (without sharp margins)
- Exquisitely tender (pain out of proportion to exam)
- Caveat - some patients present with "la belle indifference"
- May be a result of ischemic, insensate tissue[4]
- Skip lesions
- Hemorrhagic bullae (violaceous bullae)
- May be preceded by skin anesthesia (destruction of superficial nerves)
- Crepitus (in type I infections)
- Lymphangitis and lymphadenopathy are absent in necrotizing fasciitis alone[5][6]
- Lymphangitis is seen in cellulitis
- Fascia has no lymph drainage
- Swelling/edema may produce compartment syndrome
- Constitutional or toxic shock-like syndrome[7]
- Fever
- Tachycardia
- Systemic toxicity, sepsis
- Conjunctivitis
Differential Diagnosis
Skin and Soft Tissue Infection
- Cellulitis
- Erysipelas
- Lymphangitis
- Folliculitis
- Hidradenitis suppurativa
- Skin abscess
- Necrotizing soft tissue infections
- Mycobacterium marinum
Look-A-Likes
- Sporotrichosis
- Osteomyelitis
- Deep venous thrombosis
- Pyomyositis
- Purple glove syndrome
- Tuberculosis (tuberculous inflammation of the skin)
Necrotizing rashes
- Necrotizing soft tissue infections
- Purpura fulminans
- Drug rash
- Levamisole toxicity
- Heparin-induced skin necrosis
- Warfarin-induced skin necrosis
Evaluation
Work-Up
- CBC
- Chem
- PT/PTT/INR
- CK
- Lactate
Evaluation
- Surgical exploration is the ONLY way to definitively establish the diagnosis of necrotizing infection
- Imaging
- Should not delay surgical exploration
- CT is study of choice - soft tissue gas, edema and fluid collections, fascial thickening with fat stranding
- US may show thickened fascial planes, fluid between fascial planes, irregularity of the fascia, subcutaneous emphysema. The study may be limited by soft tissue gas
- MRI - T2 subcutaneous, intramuscular, and fascial edema
- Absence of gas on imaging does not exclude diagnosis, as gas may be occult and/or certain organisms do not classically produce gas (i.e. Group A Strep)
Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score[8]
Has not been prospectively validated, index of suspicion is key and 10% of the patients with a score < 6 had Necrotizing Fasciitis. A score > 6 has PPV of 92% and NPV of 96% for necrotizing fasciitis.
- CRP (mg/L) ≥150: 4 points
- WBC count (×103/mm3)
- <15: 0 points
- 15–25: 1 point
- >25: 2 points
- Hemoglobin (g/dL)
- >13.5: 0 points
- 11–13.5: 1 point
- <11: 2 points
- Sodium (mmol/L) <135: 2 points
- Creatinine (umol/L) >141: 2 points
- Glucose >180 mg/dL (10 mmol/L): 1 point
Grouping by Scores
- Low Risk: score 5 (10% of pts with score < 6 still had nec fasc)
- Moderate Risk: score 6– 7
- High Risk: score >8
HUCLA NF vs Non-NF Criteria:[9]
- Retrospective study discovered:
- WBC count >15.4(x103/mm3) OR Na <135(mmol/L)
- Associated with NF and combo of both increased likelihood of NF
- PPV 26%/NPV 99%
- Useful tool to rule out NF, not a good tool for confirming presence of NF
- Helps distinguish NF from non-NF infection, when classic 'hard' signs of NF are absent however clinical judgment should still be used in patient with high suspicion of the disease
Management
- Surgical exploration and debridement is both the definitive diagnostic modality and the definitive treatment
- Indicated in setting of severe pain, toxicity, fever, elevated CK (with or without radiographic evidence)
- Antibiotics
- Must cover gram positives, gram negatives, and anaerobes (especially GAS and clostridium)
- Piperacillin-Tazobactam 3.375-4.5g q6hr AND clindamycin 600-900mg q8hr AND vancomycin 1gm IV q12hr (consider weight base dosing of 20 mg/kg)
- In diabetics, maintain strict glycemic control (with IVFs and IV insulin if necessary)
Disposition
- Admit to ICU
See Also
- Necrotizing soft tissue infections
- Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score
- EBQ:LRINEC Score
Video
{{#widget:YouTube|id=-VC1f88MZWU}}
References
- ↑ Hakkarainen TW et al. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014 Aug. 51 (8):344-72.
- ↑ Misiakos EP et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014. 1:36.
- ↑ Wong CH, Khin LW, Heng KS, Tan KC, Low CO (2004). "The LRINEC Laboratory Rother soft tissue infections". Critical Care Medicine 32 (7): 1535–1541. doi:10.1097/01.CCM.0000129486.35458.7D. PMID 15241098
- ↑ TheHealthScience. Emergent Management of Necrotizing Soft Tissue Skin Infections. Nov 22, 2013. https://thehealthscience.com/topics/emergent-management-necrotizing-soft-tissue-skin-infections.
- ↑ Seal DV. Necrotizing fasciitis. Curr Opin Infect Dis. 2001;14(2):127–32.
- ↑ Golger A, Ching S, Goldsmith CH, Pennie RA, Bain JR. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg. 2007;119(6):1803–7.
- ↑ Puvanendran R et al. Necrotizing fasciitis. Can Fam Physician. 2009 Oct; 55(10): 981–987.
- ↑ Wong C. "The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections". Crit Care Med. 2004. 32(7):1535-41.
- ↑ Wall DB et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000 Sep;191(3):227-31.